Atherectomy Devices Market
According to Intent Market Research, the Atherectomy Devices Market is expected to grow from USD 2.3 billion in 2023 at a CAGR of 10.6% to touch USD 4.6 billion by 2030. The Atherectomy Devices Market is dominated by key players such as Boston Scientific Corporation, Medtronic plc, Johnson & Johnson (Abbott Vascular), Philips Healthcare, Avinger, Inc., Cardiovascular Systems, Inc., Edwards Lifesciences Corporation, Spectranetics (Acquired by Phillips), Straub Medical AG, Volcano Corporation (Acquired by Philips Healthcare), Asahi Intecc Co., Ltd., Endologix, Inc. and Abbott Laboratories.